SCHEMBL30142728

SCHEMBL30142728

CCCCNc1ccc(C(=O)Nc2ncc([N+](=O)[O-])s2)c(OCC)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATG4B Q9Y4P1 8/20 0.54
▸ STAT3 P40763 6/20 0.53
▸ LMNA P02545 4/20 0.53
▸ MEN1 O00255 4/20 0.53
▸ NPC1 O15118 4/20 0.53
▸ RAB9A P51151 4/20 0.53
▸ KMT2A Q03164 4/20 0.53
▸ ALDH1A1 P00352 3/20 0.53
▸ MAPT P10636 3/20 0.53
▸ PKM P14618 2/20 0.53
▸ HTT P42858 2/20 0.53
▸ SMN1; SMN2 Q16637 2/20 0.53
▸ MLNR O43193 1/20 0.53
▸ NR1I2 O75469 1/20 0.53
▸ ABCB11 O95342 1/20 0.53
▸ TP53 P04637 1/20 0.53
▸ ADRB2 P07550 1/20 0.53
▸ CHRM2 P08172 1/20 0.53
▸ ADRB1 P08588 1/20 0.53
▸ CYP3A4 P08684 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25063086 1.00 ATG4B (0.54) ATG4BSTAT3LMNAMEN1NPC1
SCHEMBL30142823 0.93 ATG4B (0.52) ATG4BSTAT3LMNAMEN1NPC1
SCHEMBL25063112 0.93 ATG4B (0.52) ATG4BSTAT3LMNAMEN1NPC1
SCHEMBL25063310 0.91 STAT3 (0.64) ATG4BSTAT3LMNAMEN1NPC1
SCHEMBL27135957 0.90 STAT3 (0.53) ATG4BSTAT3LMNAMEN1NPC1
SCHEMBL25063073 0.88 STAT3 (0.58) ATG4BSTAT3LMNAMEN1NPC1
SCHEMBL30142841 0.88 STAT3 (0.58) ATG4BSTAT3LMNAMEN1NPC1
SCHEMBL30142911 0.86 STAT3 (0.58) ATG4BSTAT3LMNAMEN1NPC1
SCHEMBL25063108 0.86 STAT3 (0.58) ATG4BSTAT3LMNAMEN1NPC1
SCHEMBL27134639 0.85 STAT3 (0.64) ATG4BSTAT3LMNAMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 — — US disclosed
EP-4157888-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS Cullgen (Shanghai), Inc. (CN) 2023-04-05 — — EP disclosed
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2023-02-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 ATG4B 901/4885STAT3 3224/4885LMNA 711/4885
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 ATG4B 901/4885STAT3 3224/4885LMNA 711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback